Effect of Helicobacter pylori cell shape on pathogenesis
幽门螺杆菌细胞形状对发病机制的影响
基本信息
- 批准号:8421121
- 负责人:
- 金额:$ 3.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-16 至 2016-03-15
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimalsAntibiotic ResistanceB-Cell LymphomasBacteriaBehaviorCampylobacter jejuniCell LineCell ShapeCell WallCellsCharacteristicsChemotaxisChronicClinicalCytoplasmDetectionDevelopmentEnzymesEpithelial CellsEpitheliumEventFlagellaFrequenciesGastric MucinGastric mucosaGastritisGastrointestinal DiseasesGelGene DeletionGenesGlycoproteinsGoalsHelicobacter pyloriHumanImmobilized CellsImmuneInfectionInflammatoryKnowledgeLeadLifeMeasuresMissionModificationMotionMucous body substanceMusNational Institute of Allergy and Infectious DiseaseOrganismPathogenesisPathogenicityPathway interactionsPattern RecognitionPeptidoglycanPlayPolymersPylorusRecyclingResearchRoleRotationShapesSolutionsSourceStomachSurfaceSwimmingTestingThickVibrio choleraeVideo MicroscopyWorkbasecell motilitycrosslinkcytokineextracellulargastrointestinalgene discoverymucosa-associated lymphoid tissuemutantneuronal cell bodyoverexpressionpathogenperiplasmretinal rodstheories
项目摘要
DESCRIPTION (provided by applicant): Helicobacter pylori is a Gram-negative helical rod-shaped bacterium that infects the stomach of 50% of all humans. H. pylori is an extracellular pathogen that is found in close proximity to the mucosal epithelial cells lining the stomach 6,7. H pylori express polar flagella on its surface, and both flagellar-based motility and chemotaxis are required for infection of the gastric mucosa 13-16. Helical cell shape is thought to enhance H. pylori's flagellar based-motility through the viscous mucus layer to allow for efficient colonization7. Our lab discovered several genes that promote normal helical cell shape in H. pylori and some of these genes are required for efficient colonization of the gastric mucosa in a mouse infection model17. Deletion of these genes individually or in tandem affect the bacteria's curvature and twist through alterations in peptidoglycan (PG) cross-linking17, resulting in distinc non-helical rod shapes (i.e. curved, "c"-shaped, and straight rods). Our preliminary studies suggest that cell shape plays a role in H. pylori's swimming velocity or some other aspect of swimming behavior. We hypothesize that helical cell shape is important for H. pylori motility and by affecting velocity and/or chemosensory directional switching, cell shape impacts H. pylori's localization within different gastric mucosal niches of the stomach. Aim 1 will characterize the effect of cell shape on motility. We will test whether helical cell shape enhances H. pylori's velocity and swimming behavior by comparing the different cell shape mutants to the wild-type helical bacteria. Using live video microscopy, we will record the swimming behavior and determine the directional switching frequency of the bacteria in purified gastric mucin, the relevant polymer for H. pylori in the stomach (aim 1A). We will also directly probe the effect of cell shape on translational motion by measuring flagellar and cell body rotation for bacterial cell immobilized in gastric mucin gel at low pH (aim 1B). Aim 2 will determine the effect of bacterial cell shape on localization of H. pylori to specific gastric niches within the stomach. Aim 3 will investigate the mechanisms by which PG fragments are delivered to host gastric epithelial cells and modulate innate immune detection. H. pylori delivers PG fragments to host gastric epithelial cells via the cag-type IV secretion apparatus (cagT4SS) to activate a major pro- inflammatory pathway through the intracellular pattern recognition molecule NOD118. NOD1-expressing cells can respond to digested PG released from H. pylori cells that accumulate muro-tripeptides18, a NOD1 agonist. Some of our cell shape mutants accumulate high levels of this agonist in the PG sacculus. Thus, the cell wall modification events that drive cell shape changes may impact the synthesis and release of PG fragments that are delivered to host gastric epithelial cells. We will generate strains that overexpress cell wall modifications enzymes to determine if perturbations in PG degradation affect delivery to host cells via the cagT4SS or by cagT4SS-independent mechanisms (aim 3A). We will also investigate the mechanisms by which PG recycling mutants cause elevated pro-inflammatory cytokine release (aim 3B).
描述(由申请人提供):幽门螺杆菌是一种革兰氏阴性螺旋杆状细菌,感染50%的人的胃。H.幽门螺杆菌是一种细胞外病原体,发现其非常接近胃粘膜上皮细胞6,7。幽门螺杆菌在其表面上表达极性鞭毛,并且胃粘膜的感染需要基于鞭毛的运动性和趋化性13-16。螺旋细胞形状被认为是增强H。幽门螺杆菌的鞭毛为基础的运动通过粘性粘液层,以允许有效的殖民7。我们的实验室发现了几个促进H中正常螺旋细胞形状的基因。幽门螺杆菌和这些基因中的一些是在小鼠感染模型中胃粘膜的有效定殖所需的17。单独或串联删除这些基因会通过肽聚糖(PG)交联的改变影响细菌的曲率和扭曲17,从而产生明显的非螺旋杆形状(即弯曲、“c”形和直杆)。我们的初步研究表明,细胞形状在H。pylori的游泳速度或游泳行为的其他方面。我们假设螺旋细胞的形状对H. pylori运动性,并通过影响速度和/或化学感觉方向转换,细胞形状影响H. pylori在胃的不同胃粘膜龛内的定位。目的1将表征细胞形状对运动性的影响。我们将测试螺旋细胞形状是否增强H。pylori的速度和游泳行为,通过比较不同细胞形状的突变体与野生型螺旋细菌。利用实时视频显微镜,我们将记录游泳行为,并确定细菌在纯化的胃粘蛋白中的方向转换频率,胃粘蛋白是H。胃中的幽门螺杆菌(目的1A)。我们还将通过在低pH下测量固定在胃粘蛋白凝胶中的细菌细胞的鞭毛和细胞体旋转来直接探测细胞形状对平移运动的影响(目的1B)。目的2探讨细菌细胞形态对H. pylori与胃内的特定胃龛。目的3探讨PG片段进入宿主胃上皮细胞并调节天然免疫检测的机制。H.幽门螺杆菌通过cag-type IV分泌器(cagT 4SS)将PG片段递送至宿主胃上皮细胞,以通过细胞内模式识别分子NOD 118激活主要的促炎途径。表达NOD 1的细胞可以对H.幽门螺杆菌细胞,积累muro-三肽18,NOD 1激动剂。我们的一些细胞形状突变体在PG球囊中积累高水平的这种激动剂。因此,驱动细胞形状变化的细胞壁修饰事件可能影响递送至宿主胃上皮细胞的PG片段的合成和释放。我们将产生过表达细胞壁修饰酶的菌株,以确定PG降解的扰动是否影响通过cagT 4SS或通过cagT 4SS非依赖性机制递送至宿主细胞(目的3A)。我们还将研究PG再循环突变体引起促炎细胞因子释放升高的机制(目的3B)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura Elizabeth Martinez其他文献
Laura Elizabeth Martinez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura Elizabeth Martinez', 18)}}的其他基金
Effect of Helicobacter pylori cell shape on pathogenesis
幽门螺杆菌细胞形状对发病机制的影响
- 批准号:
8812769 - 财政年份:2012
- 资助金额:
$ 3.47万 - 项目类别:
Effect of Helicobacter pylori cell shape on pathogenesis
幽门螺杆菌细胞形状对发病机制的影响
- 批准号:
8257854 - 财政年份:2012
- 资助金额:
$ 3.47万 - 项目类别:
Effect of Helicobacter pylori cell shape on pathogenesis
幽门螺杆菌细胞形状对发病机制的影响
- 批准号:
8617793 - 财政年份:2012
- 资助金额:
$ 3.47万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 3.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 3.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 3.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




